The DOI matches its Crossref record; 139 of the 140 references it cites were found in a registry or an index.
Network medicine: a network-based approach to human disease
Open accessAbstract
Given the functional interdependencies between the molecular components in a human cell, a disease is rarely a consequence of an abnormality in a single gene, but reflects the perturbations of the complex intracellular and intercellular network that links tissue and organ systems. The emerging tools of network medicine offer a platform to explore systematically not only the molecular complexity of a particular disease, leading to the identification of disease modules and pathways, but also the molecular relationships among apparently distinct (patho)phenotypes. Advances in this direction are essential for identifying new disease genes, for uncovering the biological significance of disease-associated mutations identified by genome-wide association studies and full-genome sequencing, and for identifying drug targets and biomarkers for complex diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Few genes act in isolation but rather affect the function of other genes to influence a particular phenotype via in cellular networks or pathways (Barabasi et al., 2011; Geschwind and Konopka, 2009).”
From Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders (2019) · cites this paper as Barabasi et al., 2011
In the citing paper
“Communities of co-expressed proteins can be linked to disease processes, and the most strongly correlated proteins, or “hubs,” within these co-expression modules are enriched in key drivers of disease pathogenesis5–10.”
In the citing paper
“Machine learning has been used to analyze high-throughput molecular interactomes to unravel genetic architecture perturbed in disease12,13 and help design therapies to target them14.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [14]
In the citing paper
“This evaluation method aligns with the approach predominantly used in the literature12,14–16,18–20.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [14]
In the citing paper
“TxGNN leverages an additional metric learning component for zero-shot prediction, capitalizing on the insight that diseases can share disease-associated genetic and genomic networks10,14 and, thus, medical knowledge of disease-associated networks can be transferred by the model from well-annotated diseases to other diseases to enhance predictions on diseases with limited treatment options (Fig. 2a”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [14]
In the citing paper
“In protein interaction networks, for instance, mutations in interacting proteins often lead to similar diseases [13].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Further, essential genes are often found in hubs of a molecular network whereas non-essential genes (e.g., those associated with disease) are located on the periphery [13].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Given by the shared components and disease module hypotheses [13], cellular components associated with the same phenotype tend to cluster in the same network neighborhood [16].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Thus, the network parsimony principle dictates that shortest molecular paths between known disease-associated components tend to correlate with causal molecular pathways [13].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“First, interacting entities are typically more similar than non-interacting entities, as implicated by the local hypothesis [13].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“The organizing principles governing networks link network structure to molecular phenotypes, biological roles, disease, and health, thus providing the conceptual grounding that, we argue, can explain the successes (and limitations) of graph representation learning and inform future development of the field.”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Because such processes are costly and time-consuming, in silico approaches have been adopted into the drug discovery pipeline.”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Modern drug discovery requires elucidating a candidate drug’s chemical structure, identifying its drug targets, quantifying its efficacy and toxicity, and detecting its potential side effects [13, 14, 32, 164].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collective dynamics of ‘small-world’ networks
Watts, D. J., & Strogatz, S. H. (1998) · Nature · doi:10.1038/30918 · Cited by 43,060
Emergence of Scaling in Random Networks
Barabási, A.-L., & Albert, R. (1999) · Science · doi:10.1126/science.286.5439.509 · Cited by 36,135
Self-citationStatistical mechanics of complex networks
Albert, R., & Barabási, A.-L. (2002) · Reviews of Modern Physics · doi:10.1103/revmodphys.74.47 · Cited by 20,471
Self-citationCommunity structure in social and biological networks
Girvan, M., & Newman, M. E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122653799 · Cited by 15,502
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Self-citationNetwork motifs: simple building blocks of complex networks.
Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D., & Alon, U. (2002) · Science · doi:10.1126/science.298.5594.824 · Cited by 7,368
Uncovering the overlapping community structure of complex networks in nature and society
Palla, G., Derényi, I., Farkas, I., & Vicsek, T. (2005) · Nature · doi:10.1038/nature03607 · Cited by 5,373
Lethality and centrality in protein networks
Jeong, H., Mason, S., Barabási, A., & Oltvai, Z. (2001) · Nature · doi:10.1038/35075138 · Cited by 5,327
Self-citationThe Large-Scale Organization of Metabolic Networks
Jeong, H., Tombor, B., Albert, R., Oltvai, Z. N., & Barabási, A.-L. (2000) · Nature · doi:10.1038/35036627 · Cited by 4,972
Self-citation
Cited by
Sorted by citations
Items 501–600 of 1,013
Discriminating Different Classes of Biological Networks by Analyzing the Graphs Spectra Distribution
Takahashi, D. Y., Sato, J. R., Ferreira, C. E., & Fujita, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049949 · Cited by 74
Blizinsky, K. D., Diaz-Castro, B., Forrest, M. P., Schürmann, B., Bach, A. P., Martin-de-Saavedra, M. D., Wang, L., Csernansky, J. G., Duan, J., & Penzes, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607014113 · Cited by 76
Network-Based Approaches for Multi-omics Integration
Zhou, G., Li, S., & Xia, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0239-3_23 · Cited by 78
Next-generation drug repurposing using human genetics and network biology
Nabirotchkin, S., Peluffo, A. E., Rinaudo, P., Yu, J., Hajj, R., & Cohen, D. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.12.004 · Cited by 77
Advances in protein-protein interaction network analysis for Parkinson's disease
Tomkins, J. E., & Manzoni, C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105395 · Cited by 78
Diverse Ways of Perturbing the Human Arachidonic Acid Metabolic Network To Control Inflammation
Meng, H., Liu, Y., & Lai, L. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00226 · Cited by 76
ModuleDiscoverer: Identification of regulatory modules in protein-protein interaction networks
Vlaic, S., Conrad, T., Tokarski, C., Gustafsson, M., Dahmen, U., Guthke, R., & Schuster, S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18370-2 · Cited by 80
Tsuji, S., Hase, T., Yachie-Kinoshita, A., Nishino, T., Ghosh, S., Kikuchi, M., Shimokawa, K., Aburatani, H., Kitano, H., & Tanaka, H. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00826-3 · Cited by 75
Network medicine, multimorbidity and the lung in the elderly
Faner, R., Cruz, T., López-Giraldo, A., & Agustí, A. G. N. (2014) · European Respiratory Journal · doi:10.1183/09031936.00078714 · Cited by 74
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
Kumar, R., Harilal, S., Gupta, S. V., Jose, J., Parambi, D. G. T., Uddin, M. S., Shah, M. A., & Mathew, B. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111602 · Cited by 78
DOMINO: a network‐based active module identification algorithm with reduced rate of false calls
Levi, H., Elkon, R., & Ron Shamir, A. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209593 · Cited by 76
Choudhuri, S., Yendluri, M., Poddar, S., Li, A., Mallick, K., Mallik, S., & Ghosh, B. (2023) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases1020008 · Cited by 83
The role of pathogen genomics in assessing disease transmission
Sintchenko, V., & Holmes, E. C. (2015) · BMJ · doi:10.1136/bmj.h1314 · Cited by 75
Prediction of disease–gene–drug relationships following a differential network analysis
Zickenrott, S., Angarica, V. E., Upadhyaya, B. B., & del Sol, A. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.393 · Cited by 77
Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells
Guo, Y., Bao, C., Ma, D., Cao, Y., Li, Y., Xie, Z., & Li, S. (2019) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00237 · Cited by 77
Systems Biology Brings New Dimensions for Structure-Based Drug Design
Pei, J., Yin, N., Ma, X., & Lai, L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504810z · Cited by 74
SAveRUNNER: an R-based tool for drug repurposing
Fiscon, G., & Paci, P. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04076-w · Cited by 78
A Mini Review of Node Centrality Metrics in Biological Networks
Wang, M., Wang, H., & Zheng, H. (2022) · International Journal of Network Dynamics and Intelligence · doi:10.53941/ijndi0101009 · Cited by 74
Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data
Xu, T., Le, T. D., Liu, L., Wang, R., Sun, B., & Li, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152792 · Cited by 75
Ritchie, S. C., Watts, S. C., Fearnley, L. G., Holt, K. E., Abraham, G., & Inouye, M. (2016) · Cell Systems · doi:10.1016/j.cels.2016.06.012 · Cited by 78
Srihari, S., Yong, C. H., Patil, A., & Wong, L. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.026 · Cited by 74
Agustí, A. G. N., Antó, J. M., Auffray, C., Barbé, F., Barreiro, E., Dorca, J., Escarrabill, J., Faner, R., Furlong, L. I., García‐Aymerich, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1935pp · Cited by 73
Wu, C.-C., Wang, Y., Livingston, J. A., Zhang, J., & Futreal, P. A. (2022) · Nature Communications · doi:10.1038/s41467-021-27651-4 · Cited by 80
A Network-Based Approach to Prioritize Results from Genome-Wide Association Studies
Akula, N., Baranova, A. V., Seto, D., Solka, J. L., Nalls, M. A., Singleton, A., Ferrucci, L., Tanaka, T., Bandinelli, S., Cho, Y. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024220 · Cited by 73
Alural, B., Genç, Ş., & Haggarty, S. J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.03.010 · Cited by 76
Mapping the Research Landscape of Nature-Based Solutions in Urbanism
Li, L., Cheshmehzangi, A., Chan, F. K. S., & Ives, C. D. (2021) · Sustainability · doi:10.3390/su13073876 · Cited by 71
Cappi, C., Brentani, H., Lima, L., Sanders, S. J., Zai, G., Diniz, B. J., Reis, V. N. S., Hounie, A. G., Conceição do Rosário, M., Mariani, D., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.30 · Cited by 71
Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence
Romeo-Guitart, D., Forés, J., Herrando-Grabulosa, M., Valls, R., Leiva-Rodríguez, T., Galea, E., González-Pérez, F., Navarro, X., Petegnief, V., Bosch, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19767-3 · Cited by 71
HyperFoods: Machine intelligent mapping of cancer-beating molecules in foods
Veselkov, K., Gonzalez, G., Aljifri, S., Galea, D., Mirnezami, R., Youssef, J., Bronstein, M. M., & Laponogov, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-45349-y · Cited by 71
Farkas, I. J., Korcsmáros, T., Kovács, I. A., Mihalik, Á., Palotai, R., Simkó, G. I., Szalay, K. Z., Szalay-Bekő, M., Vellai, T., Wang, S., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001950 · Cited by 74
Network Biology in Medicine and Beyond
Zhang, B., Tian, Y., & Zhang, Z. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000123 · Cited by 69
Eronen, L., & Toivonen, H. T. T. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-119 · Cited by 70
Translational bioinformatics: linking knowledge across biological and clinical realms: Figure 1
Sarkar, I. N., Butte, A. J., Lussier, Y. A., Tarczy-Hornoch, P. Z., & Lucila Ohno-machado, A. (2011) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000245 · Cited by 70
Blanco‐Gómez, A., Castillo‐Lluva, S., Sáez‐Freire, M. D. M., Hontecillas‐Prieto, L., Mao, J., Castellanos‐Martín, A., & Pérez‐Losada, J. (2016) · BioEssays · doi:10.1002/bies.201600084 · Cited by 72
Kalgotra, P., Sharda, R., & Croff, J. M. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.09.014 · Cited by 70
Centrality-based identification of important edges in complex networks
Bröhl, T., & Lehnertz, K. (2019) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/1.5081098 · Cited by 69
Recent advances in network-based methods for disease gene prediction
Ata, S. K., Wu, M., Fang, Y., LE, O.-Y., Kwoh, C. K., & Li, X. (2021) · Singapore Management University Institutional Knowledge (InK) (Singapore Management University) · Cited by 69
A review of dynamical systems approaches for the detection of chaotic attractors in cancer networks
Uthamacumaran, A. (2021) · Patterns · doi:10.1016/j.patter.2021.100226 · Cited by 67
Effects of Psychological Stress on Innate Immunity and Metabolism in Humans: A Systematic Analysis
Priyadarshini, S., & Aich, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043232 · Cited by 69
Understanding Genotype-Phenotype Effects in Cancer via Network Approaches
Kim, Y.-A., Cho, D.-Y., & Przytycka, T. M. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004747 · Cited by 66
PID Control for Synchronization of Complex Dynamical Networks With Directed Topologies
Gu, H., Liu, P., Lü, J., & Lin, Z. (2020) · IEEE Transactions on Cybernetics · doi:10.1109/tcyb.2019.2902810 · Cited by 71
Aguilar‐López, B. A., Moreno‐Altamirano, M. M. B., Dockrell, H. M., Duchen, M. R., & Sánchez‐García, F. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00051 · Cited by 73
Theranostics in Boron Neutron Capture Therapy
Sauerwein, W. A. G., Sancey, L., Hey‐Hawkins, E., Kellert, M., Panza, L., Imperio, D., Balcerzyk, M., Rizzo, G., Scalco, E., Herrmann, K., et al. (2021) · Life · doi:10.3390/life11040330 · Cited by 68
Genomics and transcriptomics in drug discovery
Dopazo, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.06.003 · Cited by 69
Adaptive network nanomedicine an integrated model for homeopathic medicine
Bell, I. R. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s400 · Cited by 68
Spreading of diseases through comorbidity networks across life and gender
Chmiel, A., Klimek, P., & Stefan Thurner, A. (2014) · New Journal of Physics · doi:10.1088/1367-2630/16/11/115013 · Cited by 67
Genetic heterogeneity in autism: From single gene to a pathway perspective
An, J., & Claudianos, C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.013 · Cited by 68
A systems approach to clinical oncology uses deep phenotyping to deliver personalized care
Yurkovich, J. T., Tian, Q., Price, N. D., & Hood, L. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0273-6 · Cited by 73
Li, P., Chen, J., Wang, J., Zhou, W., Wang, X., Li, B., Tao, W., Wang, W., Wang, Y., & Yang, L. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.07.001 · Cited by 68
Weishaupt, H., Johansson, P., Sundström, A., Lubovac-Pilav, Z., Olsson, B. E., Nelander, S., & Swartling, F. J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz066 · Cited by 65
Construction and Analysis of Protein-Protein Interaction Network of Heroin Use Disorder
Chen, S.-J., Liao, D., Chen, C., Wang, T., & Chen, K.-C. (2019) · Scientific Reports · doi:10.1038/s41598-019-41552-z · Cited by 68
EMODMI: A Multi-Objective Optimization Based Method to Identify Disease Modules
Tian, Y., Su, X., Su, Y., & Zhang, X. (2020) · IEEE Transactions on Emerging Topics in Computational Intelligence · doi:10.1109/tetci.2020.3014923 · Cited by 67
From time-series transcriptomics to gene regulatory networks: A review on inference methods
Marku, M., & Pancaldi, V. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011254 · Cited by 72
Defining a comprehensive verotype using electronic health records for personalized medicine
Boland, M. R., Hripcsak, G. M., Shen, Y., Chung, W. K., & Weng, C. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001932 · Cited by 67
Deep contrastive learning enables genome-wide virtual screening
Jia, Y., Gao, B., Tan, J., Zheng, J., Hong, X., Zhu, W., Tan, H., Xiao, Y., Tan, L., Cai, H., et al. (2026) · Science · doi:10.1126/science.ads9530 · Cited by 66
PATHOME: an algorithm for accurately detecting differentially expressed subpathways
Nam, S., Chang, H., Kim, K.-T., Kook, M., Hong, D., Kwon, C. H., Jung, H.-Y., Park, H. S., Powis, G., Liang, H., et al. (2014) · Oncogene · doi:10.1038/onc.2014.80 · Cited by 66
The landscape of copy number variations in F innish families with autism spectrum disorders
Kanduri, C., Kantojärvi, K., Salo, P., Vanhala, R., Buck, G., Blancher, C., Lähdesmäki, H. J., & Järvelä, I. E. (2015) · Autism Research · doi:10.1002/aur.1502 · Cited by 71
De novo variants in exomes of congenital heart disease patients identify risk genes and pathways
Bayrak, Ç. S., Zhang, P., Tristani‐Firouzi, M., Gelb, B. D., & Itan, Y. (2020) · Genome Medicine · doi:10.1186/s13073-019-0709-8 · Cited by 67
Systematically Understanding Cybersecurity Economics: A Survey
Kianpour, M., Kowalski, S. J., & Øverby, H. (2021) · Sustainability · doi:10.3390/su132413677 · Cited by 66
Advances in integrative nanomedicine for improving infectious disease treatment in public health
Bell, I. R., SCHWARTZ, G. E. R., Boyer, N. N., Koithan, M. S., & Brooks, A. J. (2012) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2012.11.002 · Cited by 66
Biological network analysis: insights into structure and functions
Ma, X., & Gao, L. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els045 · Cited by 67
Holzinger, A. (2014) · Cited by 65
The interdependent network of gene regulation and metabolism is robust where it needs to be
Klosik, D. F., Grimbs, A., Bornholdt, S., & Hütt, M. ‐. (2017) · Nature Communications · doi:10.1038/s41467-017-00587-4 · Cited by 66
MicroRNAs: master regulators of drug resistance, stemness, and metastasis
Raza, U., Zhang, J. D., & Şahin, Ö. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1129-2 · Cited by 67
Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Yao, S., Chen, Z., Yu, Y., Zhang, N., Jiang, H., Zhang, G., Zhang, Z., & Zhang, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.689533 · Cited by 68
Identifying influential spreaders by gravity model considering multi-characteristics of nodes
Li, Z., & Huang, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-14005-3 · Cited by 65
Wu, L., Wang, Y., Li, Z., Zhang, B., Cheng, Y., & Fan, X. (2014) · Chinese Medicine · doi:10.1186/1749-8546-9-24 · Cited by 65
Szilágyi, A., Nussinov, R., & Csermely, P. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313010007 · Cited by 65
Digital phenotyping of negative symptoms: the relationship to clinician ratings
Cohen, A. S., Schwartz, E. K., Le, T. P., Cowan, T., Kirkpatrick, B. W., Raugh, I. M., & Strauss, G. P. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa065 · Cited by 65
Bousquet, J. J., Jørgensen, C., Dauzat, M., Cesario, A., Camuzat, T., Bourret, R., Best, N., Antó, J. M., Abecassis, F., Aubas, P., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140314115505 · Cited by 64
Breyer‐Kohansal, R., Hartl, S., Burghuber, O. C., Urban, M. H., Schrott, A., Agustí, A. G. N., Sigsgaard, T., Vogelmeier, C. F., Wouters, E. F. �., Studnicka, M., et al. (2018) · Journal of Epidemiology · doi:10.2188/jea.je20180039 · Cited by 66
Network-based approaches for modeling disease regulation and progression
Galindez, G., Sadegh, S., Baumbach, J., Kacprowski, T., & List, M. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.022 · Cited by 74
A comprehensive review of digital twin in healthcare in the scope of simulative health-monitoring
Nadeem, M., Kostic, S., Dornhöfer, M., Weber, C., & Fathi, M. (2025) · Digital Health · doi:10.1177/20552076241304078 · Cited by 71
Unraveling the autoimmune translational research process layer by layer
Blumberg, R. S., Dittel, B. N., Hafler, D. A., von Herrath, M., & Nestle, F. O. (2012) · Nature Medicine · doi:10.1038/nm.2632 · Cited by 69
Bipartite Community Structure of eQTLs
Platig, J., Castaldi, P. J., DeMeo, D. L., & Quackenbush, J. F. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005033 · Cited by 64
Racial Differences in Four Leukemia Subtypes: Comprehensive Descriptive Epidemiology
Zhao, Y., Wang, Y., & Ma, S. (2018) · Scientific Reports · doi:10.1038/s41598-017-19081-4 · Cited by 65
Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology
Li, Y., Zhang, Y., Li, X., Yi, S. S., & Xu, J. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.03.009 · Cited by 65
Xiao, X., Moreno-Moral, A., Rotival, M., Bottolo, L., & Petretto, E. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004006 · Cited by 63
Network biomarkers, interaction networks and dynamical network biomarkers in respiratory diseases
Wu, X., Chen, L., & Wang, X. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-16 · Cited by 66
m 6 A modification patterns and tumor immune landscape in clear cell renal carcinoma
Zhong, J., Liu, Z., Cai, C., Duan, X., Deng, T., & Zeng, G. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001646 · Cited by 64
Banerjee, S., Zhao, C., Kirkby, C. A., Coggins, S., Zhao, S., Bissett, A. B., van der Heijden, M. G. A., Kirkegaard, J. A., & Richardson, A. E. (2021) · Agriculture Ecosystems & Environment · doi:10.1016/j.agee.2021.107559 · Cited by 65
Medina, I. R., & Lubovac-Pilav, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156006 · Cited by 61
FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications
Gassen, N. C., Hartmann, J., Zannas, A. S., Kretzschmar, A., Zschocke, J., Maccarrone, G., Hafner, K., Zellner, A., Kollmannsberger, L. K., Wagner, K. V., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.38 · Cited by 62
Thomson, T. M., Sewer, A., Martin, F. P., Belcastro, V., Frushour, B. P., Gebel, S., Park, J., Schlage, W. K., Talikka, M., Vasilyev, D. M., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.07.007 · Cited by 62
Genetics of extreme human longevity to guide drug discovery for healthy ageing
Zhang, Z. D., Milman, S., Lin, J.-R., Wierbowski, S. D., Yu, H., Barzilai, N., Gorbunova, V. A., Ladiges, W., Niedernhofer, L. J., Suh, Y., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0247-0 · Cited by 63
Gupta, C., Chandrashekar, P. B., Jin, T., He, C., Khullar, S., Chang, Q., & Wang, D. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09438-w · Cited by 66
How to build personalized multi-omics comorbidity profiles
Moni, M. A., & Lió, P. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00028 · Cited by 62
Heterogeneous Network Model to Infer Human Disease-Long Intergenic Non-Coding RNA Associations
Ganegoda, G. U., Li, M., Wang, W., & Feng, Q. (2015) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2015.2391133 · Cited by 62
A network approach to clinical intervention in neurodegenerative diseases
Santiago, J. A., & Potashkin, J. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.10.002 · Cited by 62
Ankers, J., Awais, R., Jones, N. A., Boyd, J., Ryan, S., Adamson, A. D., Harper, C. V., Bridge, L., Spiller, D. G., Jackson, D. A., et al. (2016) · eLife · doi:10.7554/elife.10473 · Cited by 63
Xu, J., Feng, L., Han, Z., Li, Y., Wu, A., Shao, T., Ding, N., Li, X., Deng, W., Di, X., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw587 · Cited by 62
Network growth models: A behavioural basis for attachment proportional to fitness
Bell, M. G. H., Perera, S., Piraveenan, M., Bliemer, M. C. J., Latty, T. M., & Reid, C. R. (2017) · Scientific Reports · doi:10.1038/srep42431 · Cited by 58
Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses
Islam, T., Rahman, M. R., Göv, E., Turanlı, B., Gülfidan, G., Haque, A., Arğa, K. Y., & Mollah, N. H. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0048 · Cited by 62
High‐resolution mapping of cancer cell networks using co‐functional interactions
Boyle, E. A., Pritchard, J. K., & Greenleaf, W. J. (2018) · Molecular Systems Biology · doi:10.15252/msb.20188594 · Cited by 63
Characterization of intellectual disability and autism comorbidity through gene panel sequencing
Aspromonte, M. C., Bellini, M., Gasparini, A., Carraro, M., Bettella, E., Polli, R., Cesca, F., Bigoni, S., Boni, S., Carlet, O., et al. (2019) · Human Mutation · doi:10.1002/humu.23822 · Cited by 69
Transittability of complex networks and its applications to regulatory biomolecular networks
Wu, F., Wu, L., Wang, J., Liu, J., & Chen, L. (2014) · Scientific Reports · doi:10.1038/srep04819 · Cited by 62
Hardy, W. R., Moldovan, N. I., Moldovan, L., Livak, K. J., Datta, K., Goswami, C. P., Corselli, M., Traktuev, D. O., Murray, I. R., Péault, B., et al. (2017) · Stem Cells · doi:10.1002/stem.2599 · Cited by 61
Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer
Chun, K., Park, J. H., & Fan, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6020-5_4 · Cited by 60
A computational framework for the prioritization of disease-gene candidates
Browne, F., Wang, H., & Zheng, H. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s9-s2 · Cited by 61
González‐Díaz, H., Herrera-Ibatá, D. M., Duardo-Sánchez, A., Munteanu, C. R., Orbegozo-Medina, R. A., & Pazos, A. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400716y · Cited by 61
Metadata
- Authors
- Barabási, A.-L., Gulbahce, N., & Loscalzo, J.
- Affiliations
- Northeastern University (US)
- Brigham and Women's Hospital (US)
- Venue
- Nature Reviews Genetics
- Published
- 2010-12-17
- Volume
- 12
- Issue
- 1
- Pages
- 56-68
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- PMC
- PMC3140052
- OpenAlex
- W2062533676
- Cited by
- 5,034
- References
- 140
- Citations by year
- 2026: 421 · 2025: 322 · 2024: 296 · 2023: 299 · 2022: 346 · 2021: 390 · 2020: 384 · 2019: 356 · 2018: 383 · 2017: 326 · 2016: 311 · 2015: 324 · 2014: 309 · 2013: 272 · 2012: 217
- FWCI
- 15.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL81587, HL 70819, U54HL070819, P01HL081587, R21HL089734, R01HL061795, HL-48743, P01HL048743, HL-061795, R37HL061795)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- network medicine, molecular networks, disease-associated genes, disease-associated mutations, therapeutic target, biomarkers, disease modules, complex diseases, genome-wide association study, full genome sequencing
- MeSH terms
- Disease, Humans, Gene Expression Profiling, Databases, Genetic, Gene Regulatory Networks, Metabolic Networks and Pathways, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
